| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |